Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Xiao, Yunjun ^a   Zhang, Yuan ^b   Lv, Xiaofei ^a   Su, Dongfang ^a   Li, Dan ^a   Xia, Min ^a   Qiu, Jian ^b   Ling, Wenhua ^a   Ma, Jing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Coronary artery disease; Cysteine; Homocysteine; Lipid profiles

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CREATININE; CYSTEINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; NONPARAMETRIC TEST; PREVALENCE; RISK FACTOR;

MUS;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; CYSTEINE; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 80051601594     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-137     Document Type: Article

References (27)

1. Hyperhomocysteinemia: an independent risk factor for vascular disease. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I, The New England journal of medicine 1991 324 17 1149 1155 10.1056/ NEJM199104253241701 2011158
2. Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease. Ni M, Zhang XH, Jiang SL, Zhang Y, The American journal of cardiology 2007 100 3 455 458 10.1016/j.amjcard.2007.03. 046 17659928 (Pubitemid 47094696)
3. Homocysteine lowering with folic acid and B vitamins in vascular disease. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, et al. The New England journal of medicine 2006 354 15 1567 1577 16531613
4. Homocysteine and cardiovascular disease: cause or effect? Brattstrom L, Wilcken DE, The American journal of clinical nutrition 2000 72 2 315 323 10919920 (Pubitemid 30620632)
5. The controversy over homocysteine and cardiovascular risk. Ueland PM, Refsum H, Beresford SA, Vollset SE, The American journal of clinical nutrition 2000 72 2 324 332 10919921 (Pubitemid 30623491)
6. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T, Atherosclerosis 1989 79 2-3 139 146 10.1016/0021-9150(89) 90118-4 2597223 (Pubitemid 19226322)
7. Cysteine is a cardiovascular risk factor in hyperlipidemic patients. Jacob N, Bruckert E, Giral P, Foglietti MJ, Turpin G, Atherosclerosis 1999 146 1 53 59 10.1016/S0021-9150(99)00128-8 10487486 (Pubitemid 29371861)
8. Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE, Circulation 2001 103 21 2544 2549 11382721 (Pubitemid 32521962)
9. Plasma total cysteine, mortality, and cardiovascular disease hospitalizations: the Hordaland Homocysteine Study. El-Khairy L, Vollset SE, Refsum H, Ueland PM, Clinical chemistry 2003 49 6 Pt 1 895 900 12765985 (Pubitemid 36623468)
10. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Austin RC, Lentz SR, Werstuck GH, Cell death and differentiation 2004 11 Suppl 1 56 64 15243582
11. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI, et al. Circulation research 2006 99 6 598 606 10.1161/01.RES.0000242559.42077.22 16931800 (Pubitemid 44401451)
12. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Mikael LG, Genest J Jr, Rozen R, Circulation research 2006 98 4 564 571 10.1161/01.RES.0000204825.66410.0b 16439690
13. Identification of cysteine pairs within the amino-terminal 5% of apolipoprotein B essential for hepatic lipoprotein assembly and secretion. Huang XF, Shelness GS, The Journal of biological chemistry 1997 272 50 31872 31876 10.1074/jbc.272.50.31872 9395534 (Pubitemid 28013339)
14. Compartmentation of glutathione: implications for the study of toxicity and disease. Smith CV, Jones DP, Guenthner TM, Lash LH, Lauterburg BH, Toxicology and applied pharmacology 1996 140 1 1 12 10.1006/taap.1996.0191 8806864 (Pubitemid 26329456)
15. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. Heinecke JW, Rosen H, Suzuki LA, Chait A, The Journal of biological chemistry 1987 262 21 10098 10103 3038867
16. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB, Circulation 1975 51 4 Suppl 5 40 1116248
17. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. Ubbink JB, Hayward Vermaak WJ, Bissbort S, Journal of chromatography 1991 565 1-2 441 446 10.1016/0378-4347(91)80407-4 1874890
18. Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population. Gueant-Rodriguez RM, Spada R, Moreno-Garcia M, Anello G, Bosco P, Lagrost L, Romano A, Elia M, Gueant JL, Atherosclerosis 214 2 480 485
19. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. El-Khairy L, Ueland PM, Nygard O, Refsum H, Vollset SE, The American journal of clinical nutrition 1999 70 6 1016 1024 10584046
20. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Elshorbagy AK, Nurk E, Gjesdal CG, Tell GS, Ueland PM, Nygard O, Tverdal A, Vollset SE, Refsum H, The American journal of clinical nutrition 2008 88 3 738 746 18779291
21. The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins. Elshorbagy AK, Valdivia-Garcia M, Graham IM, Palma Reis R, Sales Luis A, Smith AD, Refsum H, Nutr Metab Cardiovasc Dis
22. The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity. Elshorbagy AK, Refsum H, Smith AD, Graham IM, Obesity (Silver Spring, Md 2009 17 7 1435 1440
23. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, et al. Jama 1997 277 22 1775 1781 10.1001/jama.277.22.1775 9178790 (Pubitemid 27247163)
24. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE, Jama 2008 299 17 2027 2036 10.1001/jama.299.17.2027 18460663 (Pubitemid 351656584)
25. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygard O, Jama 2008 300 7 795 804 10.1001/jama.300.7.795 18714059
26. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM, The Journal of nutrition 1994 124 10 1934 1941 7931702 (Pubitemid 24334628)
27. Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects. Kinscherf R, Cafaltzis K, Roder F, Hildebrandt W, Edler L, Deigner HP, Breitkreutz R, Feussner G, Kreuzer J, Werle E, et al. Free radical biology & medicine 2003 35 10 1286 1292 10.1016/j.freeradbiomed.2003.07.001 21848991 (Pubitemid 37357253)